Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and tolerability study of Lecicarbon in chronic constipation
2025-522464-32-00Phase 4Authorised
- Sponsor
- Athenstaedt
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Lecicarbon in chronic constipation, sponsored by Athenstaedt. Primary endpoint: Tolerability, safety and compliance documented using complete spontaneous bowel movements. Planned start Sep 2025; status: authorised.
02
Drugs
Lecicarbon
03
Conditions
chronic constipation
Beyond the preview
Go deeper on 2025-522464-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522464-32-00.